by chuck_ltd | 30 Sep, 2016 | CHCUK News & Articles, News, Reimbursement
It is becoming more difficult to demonstrate that new treatments are cost efficient and should be included in the reimbursement scheme. A pharmaceutical company’s application to the Dental and Pharmaceutical Benefits Agency (TLV) for a pricing and reimbursement...
by chuck_ltd | 7 Jan, 2016 | CHCUK News & Articles, News, Patient Centricity
Introduction The Stockholm Administrative Court of Appeal recently considered whether financial aspects can be assessed when determining whether there are special requirements for granting a named patient permission. The court dismissed arguments that high prices and...
